Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells

Fig. 6

miR-101-3p/BIRC5 axis regulates MM cell viability in BTZ context. a,b RPMI-8226 cells were transfected transiently with cDNA ORF clone of human BIRC5 or the empty vector using lipofectamine 3000. Cells were washed 72 h after transfection, incubated with 5 nM BTZ or CFZ for 48 h and viability was examined in MTT assay (b). The same cells were also transfected in parallel with synthetic inhibitor of miR-101-3p or the scrambled control. Cell lysate was prepared 48 h after transfection and applied to WB for measuring survivin protein level. For these experiments, signals from the WB bands were captured using the ChemiDoc XRS+ System (Bio-Rad). For densitometric quantification of WB bands, we used ImageJ software. The densities of survivin bands were divided by densities of their relevant actin bands and reported as shown

Back to article page